[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371080-105":59,"doc-detail-371080-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mapping-immune-trajectories-from-helicobacter-pylori-gastritis-to-gastric-cancer","Mapping immune trajectories from Helicobacter pylori gastritis to gastric cancer","","Helicobacter pylori-associated gastric tumorigenesis is traditionally staged by histopathology, but clinical decisions often depend on immune dynamics that histology alone cannot resolve. This mini review presents a phase-specific “immune snapshot” framework that tracks immune trajectories across chronic gastritis, atrophy with intestinal metaplasia, and dysplasia or early cancer. The approach maps compact tissue and fluid assays to decision points, including normalization of stroma and vasculature, priming antigenicity, and deploying checkpoint blockade, linking stage-aware immune states to actionable intervention sequencing and risk-adapted surveillance.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mapping-immune-trajectories-from-helicobacter-pylori-gastritis-to-gastric-cancer/371080/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mapping-immune-trajectories-from-helicobacter-pylori-gastritis-to-gastric-cancer/371080.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why can histopathology alone be insufficient for staging H. pylori gastric disease?","Question",{"text":113,"@type":114},"Clinical decisions often hinge on immune dynamics that histology alone cannot resolve. Residual risk remains even after eradication when atrophy or intestinal metaplasia has already occurred.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What does the “immune snapshot” framework integrate?",{"text":118,"@type":114},"It integrates three elements: who is present in the microenvironment, how key circuits are engaged, and where these features reside, to track trajectories across disease stages.",{"name":120,"@type":111,"acceptedAnswer":121},"How can the framework support therapy sequencing and surveillance?",{"text":122,"@type":114},"It links stage-aware immune states to actionable sequencing of interventions and to risk-adapted surveillance intervals, emphasizing practical mapping from assays to decision points.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},371080,1790527995,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Mini Review  \nPUBLISHED 17 December 2025 DOI 10.3389/fimmu.2025.1693004  \nOPEN ACCESS  \nEDITED BY  \nMatteo Fassan,  \nUniversity of Padua, Italy  \nREVIEWED BY  \nJessica Gasparello,  \nUniversity of Padua, Italy  \n*CORRESPONDENCE  \nQiang Wu  \n [hunhunee@163.com](hunhunee@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 26 August 2025  \nREVISED 30 November 2025  \nACCEPTED 30 November 2025  \nPUBLISHED 17 December 2025  \nCITATION  \nSong Y, Qiu J, Wu J, Liu W and Wu Q (2025) Mapping immune trajectories from Helicobacter pylori gastritis to gastric cancer. Front. Immunol. 16:1693004 .  \ndoi: 10.3389/fimmu.2025.1693004  \nCOPYRIGHT  \n© 2025 Song, Qiu, Wu, Liu and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMapping immune trajectories from Helicobacter pylori gastritis to gastric cancer  \nYi Song 1†, Jie Qiu 2†, Jingyue Wu 3, Wenqi Liu 4 and Qiang Wu 1*  \n1 Department of Gastroenterology, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, China, 2 Department of Gastrointestinal Surgery, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, China, 3 Hebei Medical University, Shijiazhuang, Hebei, China,  \n4 Department of Thoracic Surgery, Wuhan Hospital of Traditional Chinese And Western Medicine, Wuhan, China  \nHelicobacter pylori-associated gastric tumorigenesis is typically staged by histopathology, yet clinical decisions often hinge on immune dynamics that histology alone cannot resolve. This mini review introduces a phase-speciﬁc“immune snapshot” framework that integrates three elements—who is present in the microenvironment, how key circuits are engaged, and where these features reside—to track immune trajectories across chronic gastritis, atrophy with intestinal metaplasia, and dysplasia or early cancer. Rather than cataloging markers, we emphasized a practical approach that maps compact tissue and ﬂuid assays to decision points, including when to normalize stroma and vasculature, when to prime antigenicity, and when to deploy checkpoint blockade. The novelty lies in linking stage-aware immune states to actionable sequencing of interventions and to risk-adapted surveillance intervals. By complementing histopathology with dynamic, mechanism-informed readouts that are feasible in routine practice, the framework aims to identify reversible barriers, clarify timing, and improve the effectiveness of prevention and early immunotherapy.  \nKEYWORDS  \ngastric cancer, H. pylori, immune exclusion, immune snapshot, intestinal metaplasia, risk stratiﬁcation, therapy sequencing  \n1 Introduction  \nHelicobacter pylori is one of the most prevalent chronic infections worldwide and a principal driver of the Correa cascade—from chronic active gastritis to atrophy, intestinal metaplasia, dysplasia, and ultimately gastric cancer (1) . Although eradication therapy reduces population-level risk, patients who have already reached atrophy or intestinal metaplasia retain substantial residual risk, underscoring the limits of histology-only stratiﬁcation and the need for immune-informed frameworks (2) . Beyond epithelial mutations and epigenetic drift, mounting evidence shows that dynamic remodeling of  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nthe gastric immune microenvironment—oscillating among inﬂamed, immune-excluded, and immune-desert states—critically shapes progression along this continuum.  \nIn addition to histologic and immune changes, the gastric cancer cascade is accompanied by stepwise molecular and genetic alterations, including H. pylori virulence factor-dr","cbCaisHEeTDdZDfd","https://ap.wps.com/l/cbCaisHEeTDdZDfd","pdf",2031360,"English","# Introduction\n## Immune-informed staging need\n# Immune snapshot framework\n## Mapping tissue and fluid assays to decision points\n# Immune microenvironment remodeling","[{\"question\":\"Why can histopathology alone be insufficient for staging H. pylori gastric disease?\",\"answer\":\"Clinical decisions often hinge on immune dynamics that histology alone cannot resolve. Residual risk remains even after eradication when atrophy or intestinal metaplasia has already occurred.\"},{\"question\":\"What does the “immune snapshot” framework integrate?\",\"answer\":\"It integrates three elements: who is present in the microenvironment, how key circuits are engaged, and where these features reside, to track trajectories across disease stages.\"},{\"question\":\"How can the framework support therapy sequencing and surveillance?\",\"answer\":\"It links stage-aware immune states to actionable sequencing of interventions and to risk-adapted surveillance intervals, emphasizing practical mapping from assays to decision points.\"}]","Mapping immune trajectories from Helicobacter pylori gastritis to gastric cancer | PDF",1790191200,18,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2747d132134857f95710bd3583fd303e.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eabcbc078a89b20ccbc89a2c641f5579.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc917ba8754cd531707cbab12247de65.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/043f44bc6ba0ab3739e33b32d63083d7.webp",980,1385]